Q – Quintiles Transnational Holdings Inc., the largest provider of testing services to drugmakers – is a long idea on further strength. The IPO from May has been basing tightly with a constructive buy volume pattern. The stock outperformed the tape on Tuesday.
AXP continues to be a viable short opportunity on weakness down out of this bear wedge. The stock has become quite sloppy after a multi-quarter uptrend, not unlike Visa. I would need to see the stock lose at least $75 for me to think the short thesis is being set in motion.
__________________________________________________
__________________________________________________
